A high school biology classroom first introduced Ari Wilson to laboratory research. Today, as a genetics and cell biology major in the WSU College of Veterinary Medicine, she is preparing for a future that includes a PhD in genetics and a career in biotechnology developing personalized medicines.
In this Q&A, Ari discusses her passion for understanding genetic disease, expanding equity in health care, and the experiences that shaped her path.
Why did you choose to major in genetics and cell biology?
I chose genetics and cell biology because of interests I formed in high school where I was able to gain hands-on experience with introductory wet lab techniques. That sparked my interests in bench work, the routine, hands-on work done by scientists in a lab. In addition, my biology teachers and the foundation I built in my biology courses inspired me to pursue a degree in the field.
What interests you most about the field of genetics and cell biology?
I am very interested in gene regulation and how mis-regulation of the genome causes different disease states. Our genome encodes the information that dictates who we are; mutations to our DNA or to the system that regulates gene expression can lead to disease. I want to improve the understanding of mechanisms that cause genetic diseases. With this deeper understanding, I hope to develop personalized medicines that can be used to target these diseases.
Are there any particular issues or challenges in genetics and cell biology that you are passionate about addressing?
I am passionate about addressing discrepancies that exist within the health care field. Most of the current research being conducted does not have women or people of color at the forefront; because of this, it limits disease understanding and treatments for these populations. I believe that personalized medicine, medicine tailored to one’s own genome, can be a unique and equitable way to tackle discrepancies in the healthcare field.
What are your career goals or aspirations with this degree?
I plan to pursue my PhD in genetics and then enter the biotechnology industry. I intend to create personalized medicines that can be more affordable and less harsh on the body.